Clinical Outcome of the Tal Palindrome Chronic Hemodialysis Catheter: Single Institution Experience

Marcelo Spector, Hamid Mojibian, Donna Eliseo, Jeffrey S. Pollak, Eric Reiner, Melih Arici, Michael G. Tal

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: To report the authors' clinical experience with the Tal Palindrome chronic dialysis catheter with a symmetric tip. Materials and Methods: During a 39-month period, 126 Palindrome catheters were placed consecutively in 85 patients. Follow-up was available for 115 catheters. Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded. The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well. Results: Patient ranged in age from 35 to 91 years (median, 69 years). Fifty percent of patients had diabetes. One hundred twenty-six Palindrome catheters were placed for a total of 12,046 catheter-days. The technical success rate of catheter placement was 100%. The average catheter indwell time was 105 days (range, 1-673 days). Catheters were inserted via the right (n = 107) or left (n = 19) jugular vein in all patients without insertional complication. Catheter-related infections occurred in 16 of the 115 catheters (13.9%) during the study period and culture-proved bacteremia occurred in four (3.5%). Seven exit site infections were recorded, and 10 catheters (8.7%) developed fibrin sheaths that necessitated catheter exchanges. Conclusions: Clinical experience with the Tal Palindrome hemodialysis catheter demonstrated safe and reliable use with low infection rates.

Original languageEnglish (US)
Pages (from-to)1434-1438
Number of pages5
JournalJournal of Vascular and Interventional Radiology
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2008

Fingerprint

Renal Dialysis
Catheters
Bacteremia
Infection
Catheter-Related Infections
Jugular Veins
Fibrin
Chronic Kidney Failure
Dialysis

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical Outcome of the Tal Palindrome Chronic Hemodialysis Catheter : Single Institution Experience. / Spector, Marcelo; Mojibian, Hamid; Eliseo, Donna; Pollak, Jeffrey S.; Reiner, Eric; Arici, Melih; Tal, Michael G.

In: Journal of Vascular and Interventional Radiology, Vol. 19, No. 10, 01.10.2008, p. 1434-1438.

Research output: Contribution to journalArticle

Spector, Marcelo ; Mojibian, Hamid ; Eliseo, Donna ; Pollak, Jeffrey S. ; Reiner, Eric ; Arici, Melih ; Tal, Michael G. / Clinical Outcome of the Tal Palindrome Chronic Hemodialysis Catheter : Single Institution Experience. In: Journal of Vascular and Interventional Radiology. 2008 ; Vol. 19, No. 10. pp. 1434-1438.
@article{67340de8baec4a18aea67efa8246d4e7,
title = "Clinical Outcome of the Tal Palindrome Chronic Hemodialysis Catheter: Single Institution Experience",
abstract = "Purpose: To report the authors' clinical experience with the Tal Palindrome chronic dialysis catheter with a symmetric tip. Materials and Methods: During a 39-month period, 126 Palindrome catheters were placed consecutively in 85 patients. Follow-up was available for 115 catheters. Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded. The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well. Results: Patient ranged in age from 35 to 91 years (median, 69 years). Fifty percent of patients had diabetes. One hundred twenty-six Palindrome catheters were placed for a total of 12,046 catheter-days. The technical success rate of catheter placement was 100{\%}. The average catheter indwell time was 105 days (range, 1-673 days). Catheters were inserted via the right (n = 107) or left (n = 19) jugular vein in all patients without insertional complication. Catheter-related infections occurred in 16 of the 115 catheters (13.9{\%}) during the study period and culture-proved bacteremia occurred in four (3.5{\%}). Seven exit site infections were recorded, and 10 catheters (8.7{\%}) developed fibrin sheaths that necessitated catheter exchanges. Conclusions: Clinical experience with the Tal Palindrome hemodialysis catheter demonstrated safe and reliable use with low infection rates.",
author = "Marcelo Spector and Hamid Mojibian and Donna Eliseo and Pollak, {Jeffrey S.} and Eric Reiner and Melih Arici and Tal, {Michael G.}",
year = "2008",
month = "10",
day = "1",
doi = "10.1016/j.jvir.2008.06.018",
language = "English (US)",
volume = "19",
pages = "1434--1438",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Clinical Outcome of the Tal Palindrome Chronic Hemodialysis Catheter

T2 - Single Institution Experience

AU - Spector, Marcelo

AU - Mojibian, Hamid

AU - Eliseo, Donna

AU - Pollak, Jeffrey S.

AU - Reiner, Eric

AU - Arici, Melih

AU - Tal, Michael G.

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Purpose: To report the authors' clinical experience with the Tal Palindrome chronic dialysis catheter with a symmetric tip. Materials and Methods: During a 39-month period, 126 Palindrome catheters were placed consecutively in 85 patients. Follow-up was available for 115 catheters. Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded. The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well. Results: Patient ranged in age from 35 to 91 years (median, 69 years). Fifty percent of patients had diabetes. One hundred twenty-six Palindrome catheters were placed for a total of 12,046 catheter-days. The technical success rate of catheter placement was 100%. The average catheter indwell time was 105 days (range, 1-673 days). Catheters were inserted via the right (n = 107) or left (n = 19) jugular vein in all patients without insertional complication. Catheter-related infections occurred in 16 of the 115 catheters (13.9%) during the study period and culture-proved bacteremia occurred in four (3.5%). Seven exit site infections were recorded, and 10 catheters (8.7%) developed fibrin sheaths that necessitated catheter exchanges. Conclusions: Clinical experience with the Tal Palindrome hemodialysis catheter demonstrated safe and reliable use with low infection rates.

AB - Purpose: To report the authors' clinical experience with the Tal Palindrome chronic dialysis catheter with a symmetric tip. Materials and Methods: During a 39-month period, 126 Palindrome catheters were placed consecutively in 85 patients. Follow-up was available for 115 catheters. Insertion complications, patency, catheter-related bacteremia, exit site infections, and reasons for catheter removal were recorded. The patient's initial cause of end-stage renal disease, underlying diseases, and site of access were recorded as well. Results: Patient ranged in age from 35 to 91 years (median, 69 years). Fifty percent of patients had diabetes. One hundred twenty-six Palindrome catheters were placed for a total of 12,046 catheter-days. The technical success rate of catheter placement was 100%. The average catheter indwell time was 105 days (range, 1-673 days). Catheters were inserted via the right (n = 107) or left (n = 19) jugular vein in all patients without insertional complication. Catheter-related infections occurred in 16 of the 115 catheters (13.9%) during the study period and culture-proved bacteremia occurred in four (3.5%). Seven exit site infections were recorded, and 10 catheters (8.7%) developed fibrin sheaths that necessitated catheter exchanges. Conclusions: Clinical experience with the Tal Palindrome hemodialysis catheter demonstrated safe and reliable use with low infection rates.

UR - http://www.scopus.com/inward/record.url?scp=52349087030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52349087030&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2008.06.018

DO - 10.1016/j.jvir.2008.06.018

M3 - Article

C2 - 18693044

AN - SCOPUS:52349087030

VL - 19

SP - 1434

EP - 1438

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 10

ER -